Drug major Lupin today announced the appointment of Theresa Stevens as Chief Corporate Development Officer for its global operations.
Stevens will assume full responsibility for global merger and acquisitions and specialty business strategy, Lupin said in a filing to the BSE.
Prior to joining Lupin, Stevens was with Aptalis pharma as the Chief Corporate Development Officer responsible for M&A, strategy and global business development.
